Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives

Figure 4

Various clinical scenarios and the corresponding studies where ezetimibe has been shown to be useful. The trials are arranged in a declining order of sample size with the maximum in IMROVE-IT and minimum in VYCTOR. Cardiovascular outcome trials (ACS- acute coronary syndrome; CIMT- carotid intima medial thickness).